US infant nutrition maker Mead Johnson has welcomed test results that show its infant formulas are not related to four cases of infection.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) launched an investigation after four infants in Florida, Illinois, Missouri, and Oklahoma were found to have cronobacter infections.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The agencies tested various brands, including Mead Johnson’s Enfamil, and inspected manufacturing facilities but results show the four cases are unrelated and a recall is not necessary.
A CDC statement said: “There is currently no evidence to conclude that the infant formula or nursery water was contaminated during manufacturing or shipping.”
Tim Brown, senior vice president and general manager for Mead Johnson’s North American operations, said the all-clear shows the stringency of its quality control.
He said: “We’re pleased with the FDA and CDC testing, which should reassure consumers, healthcare professionals and retailers everywhere about the safety and quality of our products. These tests also reinforce the rigour of our quality processes throughout our operations.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataRetailers including Wal-Mart Stores, Safeway Inc, Kroger and Supervalu Inc had recalled batches of Enfamil products after it emerged that a baby had died from a bacterial infection.
